CMS proposes Medicare payment rules for SNFs, 3 others
CMS has proposed Medicare payment updates for four provider types, including skilled nursing facilities (SNFs), hospices, inpatient rehabilitation facilities (IRFs), and inpatient psychiatric facilities (IPFs). These facilities are expected to see payment increases of over 2% in fiscal year 2027, alongside updates to quality reporting programs. Additionally, CMS aims to enhance oversight of hospices to combat fraud, waste, and abuse, introducing new transparency measures and stronger monitoring.
Likely Sector ETF & Stock Winners From March Jobs Report
The March jobs report showed a significant increase in non-farm payrolls, reaching 178,000, and a drop in the unemployment rate to 4.3%. Health care, transportation and warehousing, and construction sectors all experienced job growth. This article highlights specific ETFs and stocks like Health Care Select Sector SPDR ETF (XLV), iShares U.S. Aerospace & Defense ETF (ITA), and Invesco Building & Construction ETF (PKB) as potential winners from these trends.
HCA Healthcare Inc. stock outperforms competitors on strong trading day
HCA Healthcare Inc. (HCA) saw its stock rise by 2.56% to $483.92 on Monday, outperforming the broader market. The S&P 500 Index increased by 0.44% and the Dow Jones Industrial Average rose by 0.36% on the same trading day. Despite this positive movement, HCA Healthcare Inc. remains 13.05% below its 52-week high.
HCA Healthcare Authorizes a $10 Billion Buyback as the Market Fixates on Exchange Enrollment Losses
HCA Healthcare announced a new $10 billion share repurchase program and increased its quarterly dividend, following a strong Q4 2025 earnings beat and raised 2026 EPS guidance. Despite facing headwinds from ACA enhanced premium tax credit expiration and physician cost inflation, the company plans a $400 million cost-savings program. Wall Street analysts maintain a "buy" rating with a mean price target implying 15.1% upside, as HCA's operating margins and revenue growth remain robust.
Metropolis Capital Ltd Sells 195,071 Shares of HCA Healthcare, Inc. $HCA
Metropolis Capital Ltd significantly reduced its stake in HCA Healthcare by 28.9% in the fourth quarter, selling 195,071 shares. Despite this reduction, HCA Healthcare remains Metropolis Capital Ltd's 8th largest holding, making up 7.2% of its investment portfolio. The article also details other institutional investor activities, recent insider stock sales by HCA executives, updated analyst ratings, and the company's financial performance, including its increased dividend.
HCA Healthcare Inc stock: Undervalued after dip despite strong returns?
HCA Healthcare Inc.'s stock recently dipped by 11.4% to $472, despite a strong 43.2% one-year return, indicating a potential buying opportunity for investors. The company operates a vast network of hospitals and care sites across the US and UK, leveraging demographic tailwinds, technology investments, and a strong competitive position in the healthcare sector. Analysts view the stock as undervalued, with fair value estimates pushing towards $629, suggesting considerable upside if fundamentals hold leading into its Q1 earnings on April 24, 2026.
HCA Healthcare Inc stock: Undervalued after dip despite strong returns?
HCA Healthcare Inc.'s stock recently dipped by 11.4% but still boasts a 43.2% one-year return, suggesting it might be undervalued. The company operates a vast network of hospitals and care sites in the US and UK, benefiting from demographic tailwinds and strategic investments in technology and expansions. Analysts view HCA positively due to its scale, operational efficiency, and consistent growth, despite potential risks like labor shortages and regulatory pressures.
How Investors May Respond To Acadia Healthcare (ACHC) Prioritizing Cash Flow And Existing Facilities Over Expansion
Acadia Healthcare (ACHC) is shifting its strategy to prioritize cash flow and optimize existing facilities, rather than focusing solely on expansion. The company expects positive free cash flow in 2026 due to moderated capital spending and joint ventures, which could improve its financial profile. Investors should consider this new focus in light of ongoing uncertainties regarding Medicaid reimbursement and state supplemental payments.
HCA PE Ratio & Valuation, Is HCA Overvalued
This article analyzes HCA Healthcare Inc.'s valuation, concluding that it is currently in the "Fair zone." Its forward PE ratio of 15.58 is compared to a five-year average of 14.10, with a fair price estimated between $425.25 and $497.17. The analysis also explores HCA's Price-to-Book and Free Cash Flow ratios, noting that its P/S ratio is 21% above the industry average, which the article suggests may be unsustainable despite robust revenue growth.
Red Door Wealth Management LLC Decreases Stake in HCA Healthcare, Inc. $HCA
Red Door Wealth Management LLC significantly reduced its stake in HCA Healthcare (NYSE:HCA) by 73.3% in the fourth quarter, selling 16,182 shares and now holding 5,887 shares valued at $2.748 million. Despite this, HCA Healthcare reported strong Q4 earnings, beating EPS estimates, and provided positive FY2026 guidance, while also increasing its quarterly dividend. The stock maintains a "Moderate Buy" consensus rating from analysts with an average price target of $537.73.
Lawson Kroeker Investment Management Inc. NE Decreases Stake in HCA Healthcare, Inc. $HCA
Lawson Kroeker Investment Management Inc. NE significantly reduced its stake in HCA Healthcare, Inc. by 43.6% in Q4 2025, selling 22,690 shares and retaining 29,373 shares valued at $13.713 million. Despite this reduction, HCA Healthcare remains Lawson Kroeker's fifth-largest holding, representing 4.1% of its portfolio. The article also highlights recent positive analyst ratings and price target increases for HCA, alongside insider share sales and the company's strong financial performance, including beating EPS estimates and raising its quarterly dividend.
HCA Stock News Today | Earnings, Events & Price Alerts
This page provides a comprehensive overview of HCA Healthcare (HCA) stock news, events, and earnings analysis. It highlights recent news articles covering HCA's performance, ethical recognition, and investment opportunities in the healthcare sector, alongside a summary of past earnings reports.
Aberdeen Group plc Sells 37,737 Shares of ResMed Inc. $RMD
Aberdeen Group plc reduced its stake in ResMed Inc. by 13.6% in Q4 2025, selling 37,737 shares and retaining 239,236 shares valued at $57.63 million. Despite insider selling, including CEO Michael J. Farrell's sale of shares, ResMed exceeded quarterly expectations with $2.81 EPS and $1.42 billion in revenue. The company maintains a "Moderate Buy" consensus rating with an average price target near $299 and pays a quarterly dividend of $0.60, yielding approximately 1.1%.
ResMed Inc. (NYSE:RMD) Receives Average Rating of "Moderate Buy" from Analysts
ResMed Inc. (NYSE:RMD) has received an average "Moderate Buy" rating from fourteen analysts, with a consensus twelve-month price target of $299.27. Recent analyst reports show a mix of "overweight," "buy," and "hold" ratings, with some price target adjustments. Insider selling by CEO Michael J. Farrell and Director Peter C. Farrell was noted, while institutional investors like Landscape Capital Management and Nordea Investment Management increased their stakes in the company.
A Look At Surgery Partners (SGRY) Valuation After Softer Results And Rising Debt Concerns
Surgery Partners (SGRY) is facing investor caution due to weaker quarterly results, including soft sales, slower projected revenue growth, and high debt. Despite a significant share price decline, analysts still see the stock as undervalued, with a fair value of around $25.45 compared to its current $12.18, contingent on effective M&A and portfolio optimization. However, rising interest costs and slower acquisitions present risks to this valuation narrative.
Spire Wealth Management Cuts Stock Holdings in ResMed Inc. $RMD
Spire Wealth Management significantly reduced its stake in ResMed Inc. ($RMD) by 80.5% in the fourth quarter, selling 5,666 shares and retaining 1,373 shares valued at around $331,000. This comes as company insiders also offloaded shares, with Director Peter C. Farrell and CEO Michael J. Farrell selling a combined 6,991 shares. Despite insider sales, ResMed beat quarterly earnings expectations and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $299.27.
SG Americas Securities Boosts Stake in Healthcare Realty Trust
SG Americas Securities LLC significantly increased its stake in Healthcare Realty Trust Incorporated (NYSE:HR) by 152.5% in the fourth quarter of 2025, adding 127,828 shares. This investment reflects the firm's confidence in Healthcare Realty Trust's portfolio of outpatient medical facilities. The REIT's stock has fluctuated between $14.09 and $18.97 over the past year, attracting interest from other major institutional investors.
HCA Florida Palms West Hospital Names Cory Mead As New CEO
HCA Florida Palms West Hospital has appointed Cory Mead as its new Chief Executive Officer, effective March 30. Mead brings over a decade of leadership experience from HCA Healthcare, including his most recent role as CEO of HCA Florida Woodmont Hospital where he oversaw significant operational improvements and capital projects. His appointment comes as the hospital celebrates 40 years and expands with a new patient tower.
DaVita Inc. stock underperforms Thursday when compared to competitors
DaVita Inc. (DVA) stock underperformed on Thursday compared to its competitors, closing at $121.75 after a 0.25% gain. Despite the daily gain, the stock lagged behind the S&P 500 and its peers like HCA Healthcare and Universal Health Services.
Cantor Fitzgerald reiterates HCA Healthcare stock Overweight rating
Cantor Fitzgerald has reiterated an Overweight rating for HCA Healthcare (NYSE:HCA) with a $588.00 price target. The firm noted positively trending survey results indicating a favorable outlook for 2026 compared to 2025, aligning with recent analyst sentiment and upward earnings revisions. Despite an anticipated year-over-year headwind, the stock appears undervalued according to InvestingPro's Fair Value analysis.
Ambulatory Healthcare Service Market Size 2026 Emerging Demands, Share, Trends, Futuristic Opportunity, Share and Forecast To 2033 | Tenet Healthcare Corporation, HCA Healthcare Inc., Universal Health Services Inc., Encompass Health Corporation
The global ambulatory healthcare service market is projected to grow from USD 970.77 billion in 2026 to USD 1,431.01 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 5.7%. This report from Coherent Market Insights offers a detailed analysis of market segmentation, competitive landscape, regional trends, and strategic insights for decision-makers. Key companies like Tenet Healthcare Corporation, HCA Healthcare Inc., and Universal Health Services Inc. are highlighted among the top players.
Blue Trust Inc. Has $11.08 Million Stock Position in HCA Healthcare, Inc. $HCA
Blue Trust Inc. recently decreased its stake in HCA Healthcare by 10.1% in Q4 2025, now holding 23,721 shares valued at $11.08 million. Despite this, HCA Healthcare exhibits strong fundamentals, including beating Q4 EPS expectations, raising FY-2026 guidance, and increasing its quarterly dividend. The company maintains a "Moderate Buy" consensus rating from analysts, with insider selling activity also noted.
Compagnie Lombard Odier SCmA Acquires 5,495 Shares of Cheniere Energy, Inc. $LNG
Compagnie Lombard Odier SCmA increased its stake in Cheniere Energy, Inc. by 8.3%, acquiring an additional 5,495 shares to hold a total of 72,100 shares valued at over $14 million. This move is part of broader institutional investor activity in Cheniere, which recently reported strong earnings, authorized a $10 billion share buyback, and continues to pay a quarterly dividend. Analysts maintain a "Moderate Buy" rating with a consensus target price of $284.29, driven by positive sentiment around record U.S. LNG flows and geopolitical factors.
What You Need to Know Ahead of HCA Healthcare’s Earnings Release
HCA Healthcare, Inc. (HCA) is set to release its fiscal first-quarter earnings for FY2026 on April 24, with analysts expecting an 11.5% increase in EPS to $7.19 per share. The company has consistently beaten EPS estimates in the past four quarters and its shares have outperformed the broader market, surging 37.3% over the last 52 weeks. Despite a "Moderate Buy" consensus from analysts, one analyst advises a "Strong Sell."
HCA Healthcare Kicks off Month of Volunteerism and Announces $2 Million HCA Healthcare Foundation Grant to Second Harvest Food Bank of Middle Tennessee
HCA Healthcare announced a $2 million grant from its Foundation to Second Harvest Food Bank of Middle Tennessee for its new Grow for Good campus. This initiative will expand the food bank's capacity, provide healthcare partnerships, and offer nutrition education and workforce development to address the 46% increase in need since 2020. The announcement coincides with HCA Healthcare's "We Show Up for Our Communities" national volunteer initiative, where employees across the country dedicate their time to community well-being.
AI Investing Insights - Official Homepage - Intellectia AI™
This page from Intellectia AI provides news and events for the IYH stock, an iShares U.S. Healthcare ETF. It displays current and after-market pricing, along with recent headlines from sources like NASDAQ.COM, SeekingAlpha, and Benzinga, covering significant ETF withdrawals, acquisition news, and healthcare sector developments. The platform positions itself as a trusted AI tool for winning trades.
HCA Healthcare kicks off month of volunteerism and announces $2 million HCA Healthcare Foundation grant to Second Harvest Food Bank of Middle Tennessee
HCA Healthcare is donating $2 million to Second Harvest Food Bank of Middle Tennessee to support its new "Grow for Good" campus, which will expand capacity for food distribution and offer services like healthcare partnerships and nutrition education. This announcement coincides with HCA Healthcare's national "We Show Up for Our Communities" volunteer initiative for National Volunteer Month, reflecting their ongoing commitment to addressing food insecurity and community well-being. The new campus aims to provide stable, healthy futures for families amidst increased demand for food assistance.
HCA Healthcare Foundation names new leader, gives $2 million to local nonprofit
The HCA Healthcare Foundation has announced a new leader and a $2 million donation to Second Harvest Food Bank. This funding will support the non-profit's efforts. The article also touches upon previous HCA donations and leadership insights.
HCA Healthcare Kicks off Month of Volunteerism and Announces $2 Million HCA Healthcare Foundation Grant to Second Harvest Food Bank of Middle Tennessee
HCA Healthcare Foundation has announced a $2 million grant to Second Harvest Food Bank of Middle Tennessee to support the development of their new Grow for Good campus. This investment aims to double the food bank's capacity, expand services beyond food, and create a hub for community collaboration, addressing a 46% increase in need since 2020. The announcement also aligns with HCA Healthcare's annual "We Show Up for Our Communities" volunteer initiative during National Volunteer Month.
Nisa Investment Advisors LLC Acquires 12,126 Shares of HCA Healthcare, Inc. $HCA
Nisa Investment Advisors LLC increased its stake in HCA Healthcare by 20.7% in Q4, acquiring an additional 12,126 shares to hold a total of 70,580 shares valued at approximately $32.95 million. HCA reported strong Q4 earnings, surpassing EBITDA expectations with an EPS of $8.01 and a 6.7% year-over-year revenue increase, with positive FY2026 EPS guidance. Despite insider stock sales totaling $7.8 million, the company recently raised its quarterly dividend from $0.72 to $0.78 per share.
Allspring Global Investments Holdings LLC Has $68.69 Million Stock Holdings in Tenet Healthcare Corporation $THC
Allspring Global Investments Holdings LLC reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 14.9% in Q4, now holding 344,388 shares valued at $68.69 million. Other hedge funds also adjusted their positions, and institutional investors own 95.44% of the company's stock. Analysts generally maintain a "Moderate Buy" rating with an average price target of $250.56, following strong Q4 earnings where Tenet Healthcare exceeded EPS and revenue estimates and provided positive FY2026 guidance.
2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More
This article identifies two healthcare stocks, Viking Therapeutics (VKTX) and HCA Healthcare (HCA), that Wall Street analysts believe could see significant rallies of 60% or more. Viking Therapeutics is highlighted for its late-stage weight-loss drug candidate, VK2735, showing promising clinical results, while HCA Healthcare is noted for benefiting from an aging U.S. population and its leading position as a healthcare system operator. The article provides details on why each company is viewed favorably by some analysts, despite inherent risks in biotech and the long-term nature of HCA's growth.
HCA Healthcare Inc. stock rises Tuesday, still underperforms market
HCA Healthcare Inc. (HCA) stock rose 1.16% on Tuesday, closing at $473.24. This increase occurred during a strong trading session for the broader market, with the S&P 500 Index gaining 2.91% and the Dow Jones Industrial Average rising 2.49%. Despite the daily gain, which ended a five-day losing streak for the stock, HCA still underperformed the overall market.
HCA Healthcare, Inc. $HCA Shares Sold by Foster & Motley Inc.
Foster & Motley Inc. reduced its stake in HCA Healthcare by 9.0%, selling 2,925 shares. Despite this, HCA Healthcare reported strong quarterly earnings and raised its quarterly dividend. Corporate insiders, however, have been net sellers of the stock.
HCA Healthcare, Inc. (NYSE:HCA) Given Average Rating of "Moderate Buy" by Analysts
HCA Healthcare, Inc. (NYSE:HCA) has received an average "Moderate Buy" rating from analysts, with 16 out of 25 firms issuing a buy rating. The average 1-year price target is $537.73, and several firms have recently increased their price targets. The company recently beat quarterly earnings estimates, provided strong FY2026 guidance, and increased its quarterly dividend, despite some insider selling.
HCA names new CEO for TriStar StoneCrest Medical Center
HCA Healthcare has appointed Ryan LaMasters as the new CEO of TriStar StoneCrest Medical Center. LaMasters brings two decades of leadership experience from various HCA Healthcare facilities across the country to his new role. The announcement was made by the Nashville Business Journal.
VDH staff initially wanted to deny new Chesterfield HCA hospital. Why did the commissioner approve it?
Staff at the Virginia Department of Health initially recommended denying HCA Healthcare's request for a new hospital in Chesterfield County, citing no demonstrated need and hindering competition. However, State Health Commission Dr. Cameron Webb ultimately approved the project, along with two others, following an adjudication officer's recommendation, which highlighted anticipated population growth and improved access to care in the area. This decision will significantly increase bed capacity in Chesterfield County with new facilities from Bon Secours, VCU Health, and HCA Healthcare.
DAVENPORT & Co LLC Reduces Stake in HCA Healthcare
DAVENPORT & Co LLC significantly reduced its stake in HCA Healthcare by 46.3% in the fourth quarter of 2025, selling 4,416 shares and lowering its total position to 5,127 shares valued at $2.39 million. This move, reported in a 13F filing, reflects a potential shift in the investment firm's strategy or a broader reassessment of the healthcare sector, impacting a major for-profit hospital operator in the U.S.
HCA Awards And Market Performance Put Hospital Operator In Investor Focus
HCA Healthcare (NYSE: HCA) has received significant recognition, with HCA Florida Kendall Hospital named one of America’s 50 Best Hospitals and HCA Florida Highlands Hospital ranking first in Fortune’s World’s Most Admired Companies list. These awards highlight the company's clinical quality and reputation, aligning with recent strong market performance, including a 193.7% return over five years and a 62.6% gain over the past year. While these accolades support HCA's brand strength, Simply Wall St also flags potential risks such as high debt and negative shareholders' equity, advising investors to consider these factors alongside financial metrics.
HCA Healthcare Inc Stock: Stable Leader in U.S. Hospital Operations Amid Healthcare Sector Shifts
HCA Healthcare Inc (ISIN: US42225T1079) is a leading U.S. hospital operator, known for its extensive network and focus on acute care. The company navigates the healthcare sector through operational efficiency, strategic acquisitions, and a strong market position, benefiting from demographic tailwinds and consistent financial performance. While facing regulatory and labor challenges, HCA remains a stable investment for North American portfolios seeking exposure to essential healthcare infrastructure.
SG Americas Securities Boosts Stake in Pinnacle Financial Partners
SG Americas Securities significantly increased its stake in Pinnacle Financial Partners by over 2,600% in the fourth quarter of 2025, according to a recent SEC filing. The institutional investor now owns approximately 129,779 shares, indicating confidence in the regional bank's growth potential. This substantial increase suggests that SG Americas sees strong prospects for Pinnacle Financial Partners, a bank with a significant presence in Nashville and expanding across the Southeast.
HCA Healthcare Inc Stock: Stable Leader in U.S. Hospital Operations Amid Healthcare Sector Shifts
HCA Healthcare Inc is presented as a stable leader in the U.S. hospital sector, operating a vast network of facilities focused on acute care. The article highlights its robust business model, competitive strengths, and strong financial performance, making it a relevant investment for North American portfolios seeking defensive healthcare exposure. Despite regulatory and labor risks, HCA's scale and operational efficiency position it well for continued growth amid demographic tailwinds.
Wedge Capital Management L L P NC Has $34.95 Million Stock Position in HCA Healthcare, Inc. $HCA
Wedge Capital Management L L P NC reduced its stake in HCA Healthcare by 15.3% in Q4 2025, now holding 74,855 shares valued at $34.95 million. Despite insider selling, several analysts have issued "Buy" ratings and raised price targets, contributing to a "Moderate Buy" consensus. HCA also increased its quarterly dividend to $0.78 per share.
How Investors May Respond To Acadia Healthcare (ACHC) Admissions Slowdown And Mounting Profitability Pressures
Acadia Healthcare (ACHC) is facing challenges with slowing admissions growth, declining earnings per share, and a weaker free cash flow margin, indicating increasing capital intensity and financial strain despite revenue expansion. The company recently reported 52,170 quarterly admissions, and these trends suggest pressure on operational efficiency. Investors should consider how these issues, coupled with a recent leadership change and modest volume guidance, will impact Acadia Healthcare's investment narrative and risk-reward profile.
Exchange Traded Concepts Boosts Stake in HCA Healthcare
Exchange Traded Concepts LLC increased its stake in HCA Healthcare by 31.0% during the fourth quarter, now owning 50,139 shares valued at $23.4 million. This move signals growing institutional investor confidence in HCA Healthcare, given its strong performance and resilience, especially during the COVID-19 pandemic. Investors are now watching for HCA Healthcare's upcoming quarterly earnings report to assess its continued financial strength and growth.
HCA Healthcare, Inc. $HCA Shares Acquired by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC has increased its stake in HCA Healthcare by 31.0%, bringing their total holdings to 50,139 shares valued at $23.41 million. This increase contributes to HCA's significant institutional ownership of 62.73%. The company also reported strong quarterly earnings, exceeding EPS expectations, raising its FY2026 guidance, and increasing its quarterly dividend from $0.72 to $0.78.
Eagle Rock Investment Company LLC Has $7.86 Million Stock Holdings in HCA Healthcare, Inc. $HCA
Eagle Rock Investment Company LLC reduced its stake in HCA Healthcare, Inc. by 22.2% in the fourth quarter, holding 16,832 shares valued at $7.86 million, representing 1.1% of its portfolio. Other institutional investors like Cerity Partners LLC and National Pension Service significantly increased their holdings in HCA Healthcare. Analysts currently rate HCA Healthcare as a "Moderate Buy" with a consensus price target of $537.73, and the company recently increased its quarterly dividend.
Assenagon Asset Management S.A. Lowers Stock Holdings in Tenet Healthcare Corporation $THC
Assenagon Asset Management S.A. significantly reduced its stake in Tenet Healthcare Corporation by 82.7% in the fourth quarter of 2025. Despite this sale, other major institutional investors, including Norges Bank and Eminence Capital LP, substantially increased their positions, leading to 95.44% institutional ownership. Tenet Healthcare reported strong Q4 earnings, beating estimates, and analysts maintain a "Moderate Buy" rating with a target price of $250.56.
HCA Healthcare Inc Stock: Dominant U.S. Hospital Operator Positions for Long-Term Growth Amid Sector Shifts
HCA Healthcare Inc, a leading for-profit hospital chain, is expanding its presence across the U.S. and is anticipated to report Q1 2026 earnings on April 24, 2026. The company operates a vast network of hospitals and care sites, emphasizing operational efficiency, strategic acquisitions, and technology investments. Despite facing reimbursement pressures and labor costs, HCA's scale, market positioning in high-growth states, and focus on high-acuity cases position it for continued long-term growth and stability within the healthcare sector.
HCA Healthcare Inc Stock: Dominant U.S. Hospital Operator Positions for Long-Term Growth Amid Sector
HCA Healthcare Inc, a leading for-profit hospital chain, is expanding its operations in key U.S. markets and diversifying its services to include freestanding emergency rooms and ambulatory surgery centers. The company is preparing for its Q1 2026 earnings call, where investors will look for insights into its operational resilience amidst industry shifts, including reimbursement pressures and labor costs. HCA's strategic growth initiatives, significant market presence in high-growth states, and robust institutional ownership position it for long-term stability and growth within the resilient healthcare sector.
